Healthcare -
Biotechnology - NASDAQ - US
$ 7.675
-2.23 %
$ 407 M
Market Cap
-3.69
P/E
STOK - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities STOK - Stoke Therapeutics, Inc.
53 M
LAST VALUE
542.52%
2 YEAR CAGR
-14.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR